(CRMZ)
 Preview
This is a Preview, click here for the full commercial credit report.
Salix Pharmaceuticals, Ltd.
1700, Perimeter Park Drive
Phone: (919) 862-1000Morrisville, NC  27560  United StatesTicker: SLXP
Business Summary
Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract. The Company’s products include XIFAXAN, MOVIPREP, OSMOPREP, VISICOL, APRISO, METOZOLV, AZASAN, ANUSOL-HC, PROCTOCORT cream, PEPCID, Oral Suspension DIURIL and COLAZAL. The Company’s products under development include Rifaximin, Crofelemer, Balsalazide disodium tablet and Budesonide foam.
(Source: 10-K)
 
Financial Information
Financial Ratings:Z'' Score  FRISK Score
Latest Financial Statements
and Analyses:		6/30/2010    Annual Financials    Quarterly Financials    
Current Fiscal Period:2Q 2010
Fiscal Year End:December
Last Audit:12/31/2009
Auditors:PricewaterhouseCoopers LLP
Audit Opinion:Unqualified with Explanation
Other Statements:Trade Payment History    
SEC Filings:Management Discussion & Analysis    Full Filings    
 
News Stories
Date
Headline
8/11/2010Salix Pharmaceuticals, Ltd. -- updated financials available
8/9/2010SALIX PHARMACEUTICALS LTD FILES (8-K) Disclosing Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
8/9/2010SALIX PHARMACEUTICALS LTD: a Form 10-Q has been Filed with the SEC
125 additional News Stories available in full report.
 
Industries
Type
Code
Description
SectorHEALTHHealthcare
IndustryBIOTRXBiotechnology & Drugs
SIC2834Pharmaceutical Preparations
NAICS325412Pharmaceutical Preparation Manufacturing
 
Management

Title

Name

Age
Title
Date
Start
Date
Chairman of the BoardJohn F. Chappell739/2/200312/1/1993
President, Chief Executive Officer, DirectorCarolyn J. Logan617/15/20026/14/2000
Chief Financial Officer, Executive Vice President - Finance and AdministrationAdam C. Derbyshire441/1/20096/1/2000
5 additional Management records available in full report.
 
Business Names
Business Name
Corbec Pharmaceuticals, Inc.
Glycyx Pharmaceuticals, Ltd.
InKine Pharmaceutical Company, Inc.
Salix Pharmaceuticals, Inc.
Sangen Pharmaceutical Company
 
General Information
Number of Employees:395 (As of 12/31/2009)
Outstanding Shares:57,816,021 (As of 8/7/2010)
Shareholders:242 (As of 12/31/2009)
Stock Exchange:NASD
Federal Tax Id:943267443
Fax Number:(919) 862-1095
Email Address:investor.relations@salixpharm.com
 

Home | Directory | About Us | Products | Service Options | Pricing | Register | Contact Us | Testimonials | Hours of Availability | Careers | Events | Resources | Investors | Sign In
 
Copyright © by CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.
By using this website, you accept the Terms of Use Agreement.
Contact Us: 845.230.3000